Editorial expression of concern: Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway

Reproductive Biology and Endocrinology 2026 Open access

Read full text

Authors: Jian Guo, Andrew V. Schally, Márta Zarándi, József L. Varga, Peter C. K. Leung

DOI: 10.1186/s12958-026-01533-0

Cited by: 0

References: 1

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Growth Hormone and Insulin-like Growth Factors PI3K/AKT/mTOR signaling in cancer

References 1